<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 337 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page336.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=337">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 337 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 337</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=337"><img src="../thumb/337.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>300 / 2020-04                                                           Endocrine System - 19.5
   Dosage: Admin.by IV inj./IV infus./IM inj. Cons. long-act.inject./  Special precautions: Slow withdr., cirrhos., hypothyroid.,   foll.expos.to emot./physic.stress, monit.infts.of mothers rec.prolong.
   oral prep.foll. init.ther. Init. IV admin. over 30 sec.(100 mg)-10 mins.  ocul.H.simplex, emot.instabil., ulcerat. colit., diverticulos., fresh in-  high dos.ther.for adren. insuffic., immunisat., diverticulit., non specif.
   (500 mg).May be repeat.at interv.of 4-6 hrs.accord.to pt. respons.   testin. anastomos., pept.ulc., ren.insuffic., hypertens., osteoporos.,   ulcer. colit., recent intestin.anastamos., act./ latent pept.ulc., myasth.
   & clinic.condit. Infts.& childr: Determ.by sev of condit. & pt. re-  myasth.grav., diabet., stress., monit. child growth., may mask in-  grav., osteoporos., ren. funct. impairm., hypertens., ocul.H.simplex,
   spons.but not less than 25 mg/day. High-dos. ther.to be contin.only   fects., restrict diet. salts., use low.poss.effect.dos, withdraw grad.,   ac. psychos., gluc.intol., grad.withdr., oral poliovirus vaccin., other
   until pt.condit. stabilis. usuall.not long.than 48-72 hrs. Ther.may be   latent TB/tuberculin reactiv.as reactivat. of dis. may occur., restrict.   vaccin., concom.salicylates in hypoprothrombinaem., poss.incr./
   replac.with a corticoid caus.little/no sod. retent. if hypernatraem.  use in act. TB to fulminat./ disseminat. TB where corticoster.is used   prolong.resp. depress. /paralys.with concom.non-depolar. neuro-
                                                                            +
   occurs. Admin.low.effect. dos. for short.per. Consid.other dos.forms   for manag. of dis. in conjunct.with appropr.anti-TB regim., benef.vs.   musc. block.agents, monit.ser.K  conc.& card. funct.with concom.
   in prolong. treatm. Ref.to PI for sugg.dos.regim.  risk in pregn., observ.infts.born to moth.receiv. substant.corticoster.  K deplet.diuret., antidiabet. agent/oral & insulin, monit.INR, withdr.
                                                               +
   Contraindications: Syst. fung.infects.unless spec. anti-infect.  dos.for signs of hypoadrenal., prolong.use may produc. poster. sub-  anticholinesterase agents 24 hrs.prior to ther., reg. urin.analys./2hr
   ther.init., H.simpl.keratit., ac. psychos., TB, concom.live/live at-  capsul. cataracts/glauc.  postprand.bld.sugar/BP/weight monit./ chest X-ray at reg.interv.dur.
   tenuat.vacc.                 Drug interactions: Ca excret.incr., aspir.incr. hypoprothrombin.  prolong.ther., upper GI X-ray with sev.dyspeps./ulc.hist., poss. reduc.
                                                                   +
   Side effects: Infect.aggravat./mask., anaphylax., seiz., flush.,   Na intake/ K suppl.esp.with high dos.prolong.ther.
   adrenocort.insuff., menstr.irreg., weight gain, CCF, eye disords.incl.  MYLAN METHYLPREDNISOLONE, (Mylan) Xixia [N/P/S in C]  Drug interactions: Poss.convuls.with concom. ciclospor., effic.
   glauc.with opt. nerve damage, sudd.blindn., psych./CNS disords.,   Methylprednisolone hydrogen succinate equiv.to methylpred-  poss.reduc.with concom.hepat. enzyme induc.(e.g. rifampicin/
   incr. IC press., sweat., headache, vertigo, dizzin., BP incr., salt/wa-  nisolone.  carbamazepine/ phenytoin), adv.effs.poss.incr.with erythromycin/
           +
   ter retent., incr.Ca/K  excret., GI disords. incl.bleed., oesophag.ul-  Indications: Prim./ second.adrenocort.insuff., rheumat.disords.,   ketoconazole, poss potent.the replicat.of vaccin. virus with live vac-
   cer., pancreatit., incr. appet., hiccups, skin reacts.incl.thinn., acne,   collagen dis., dermatolog. & haematology. disords., allerg.condit.,   cin., salicylates incr.salicylate excret., blockade of non-depolaris.
   delay. wound heal., osteoporos.revers.with diffic., spontan. fract.,   GI dis., cerebr.oed., ac.multip.scleros.exacerbat., as adjunct. ther.  neuromusc. block agents poss.enhanc., incr.infect.risk with other
   asept.necros.of humerus/femur. head, weakn., myopathy, tend.  in ac.spinal cord inj.with.8 hrs of inj., shock second.to adrenocort.  immunosuppress., sev.hypokalaem.with K-deplet. diuret./carbonic
   rupt., loc.reacts., musc. weakn./atrophy, prot.catabol., electrol.   insuff./unrespons.to convent. ther., organ transplant., palliat.leu-  anhydrase inhibit./ amphotericin B, digox.incr.card.arrhythm risk as-
   imbal., alter.gluc.metab., withdr.syndr.with too rapid dos.reduct.,   kaem./ lymphoma treatm., adjunct.ther.for N&V assoc. with Ca ther.  soc. with hypokalaem., coumar.anticoag. effs. enhanc., sev.weakn.
   post.subcaps.cataract/glauc. with opt.nerve damage/poss.second.  (S4) INJ. 42/21.5.1/0309, 0311, 0312  in myasth.grav.pts.with anticholinesterase agents, reduc.hypotens.
   ocul.infects. with prolong.use.  717086-001: 40 mg, 1 vial, R22,10  with antihypertens.
   Warnings and special precautions: Poss. anaphylact.reacts   717229-001: 500 mg, 1 vial, R194,02
   with rapid high dos.IV admin., emerg. treatm.facilit.to be avail.,   717230-001: 1 000 mg, 1 vial, R388,02  PANAFCORT, AI Pharm Ltd [N/P/S in C]
   TB poss.reactiv./ exacerbat., admin.concurr.appropr.antitubercul.   Dosage: Adults: As adjunct.in life-threaten. condits.: 30 mg/  Prednisone.
   chemother. or prophylax., diverticulit., non-spec. ulcer. colit.if per-  kg IV over at least 30 mins. May be repeat.4-6 hrly for up to 48 hrs.   Indications: Sev./ac.rheumat., dermatol.& allerg. condits., collagen
   forat./abscess/other infect.risk, rec. intest.anastomos., act./latent   Poss.pulse dos. in corticoster.-respon dis.in exacerbat.& unre-  dis., musc.-skelet. condits.
   pept.ulc., myasth. grav.poss.lead.to resp.distress, osteoporos.,   spons. to std.ther.  (S4) TABS. G3054.
   Cushing syndr., ren.funct.impairm., hypertens., ocul.H simpl.poss.  SLE: 1 g/day IV for 3 days.  752304-119: 5 mg, 1 000, R149,13
   result.in perforat., ac. psychos./diab.mellit.poss.aggrav., gluc.intol.,   MS: 1 g/day IV for 3 - 5 days.  Dosage: 2-20 tabs.dly.in div.dos.
   prev. corticoster.-induc.myopathy, liv.fail./cirrhos., epilep., throm-  Oed.states: 30 mg/kg IV on alt.days x4 days or 1 g/day IV for 3,5 or   Contraindications: Pept.ulc., osteoporos., psychos./sev.psycho-
   bophlebit.predisp., hypothyroid., grad. withdr., withdr.syndr.aft.too   7 days. Admin.over at least 30 mins.& may be repeat.if no improvem.  neuros., ac.bact.infect., eye ulcerat., vir.infect., vaccinat.
   rapid dos. reduct., concurr.immunisat.not advis., monit.infts. for   within a wk. aft.ther./accord.to pt.condit.  Side effects: Electrol.disturbs., induc.CF, excess. metabol.eff., incr.
   adren. insuff.whose mothers receiv.prolong. ther. with high dos.,   Ac.spin.cord.injury: Begin within 8 hrs.of injury. Adjunct.ther:   appet., delay.wound heal., pept. ulcerat./haemorrh./perforat., incr.
   concom.salicylat.in pts.with hypoprothrombinaem., ser.K  monit.if   30 mg/kg bm IV in a bolus dos.over 15 mins, follow.aft.45 min.pause   suscept.to infect., ac.adren.insuff., large dos.may produce sympt.
                           +
   giv.for prolong. per./card.funct.with diurets./carbon. anhydr. inhib./  by contin.infus.of 5,4 mg/kg bm/hr for 23 hrs, then stop abruptly.   typic.of adren.cortex.hyperactiv., ment.& neurolog. disturbs., amen-
   amphotericin B, INH monit., withdr. anticholinest. agents 24 hrs.  Separ.IV site for infus.pump need.  orrh., IC hypertens., may mask reduct.in lymphocyt., polyarterit.,
   bef.init.ther., safety & effic. in pregn.& lactat.not est., teratogen.  Adjunct.ther.for N&V prevent.assoc.with Ca chemother: Mild   thrombo-embol. complicat.
   in anim., excret. in breast milk, dimin.respons.to inactiv./kill. vac-  to mod. emetogenic ther: 250 mg IV over at least 5 min, 1 hr. bef.   Special precautions: CHF, diab.mellit., infect. dis., chron.ren.fail.,
   cin., pept.ulc., thromboembol.tenden., diab. mellit., glauc., loc./  chemother, at start.of chemother.& at discharge. Sev.emetogen.  uraem., elderly, quiesc.TB.
   system.infect., fung./other exanthem. dis., poss.growth retard.  chemother: 250 mg IV over at least 5 min.with metoclopramide   Drug interactions: Reduc.eff.with barbits., phenylbutazone, phe-
   in childr.with dos. 6 mnths.& long., contin.pt.monit. aft.discont. in   or a butyrophenone 1 hr.bef.chemother., then 250 mg IV at start.of   nytoin., rifampicin.reduc. respons.to anticoag.
   case sev.dis.sympt.re-appear, hypernatraem., monit. adrenocort.  chemother.& at discharge.  PHARMA-Q BETAMETHASONE INJECTION 4 mg/1 ml,
   insuff.S&S, incr.rapid.-act. corticoster. dos.bef./dur./aft.stressf.  Other indicat: 10-500 mg IV depend.on sev.of condit. Larg.dos.  Pharma-Q [N/P/S in C]
   situat., may mask infect. signs/enhanc.infect.organism dissemi-  may be reqd.for short term treatm. of sev.ac.condits. Init.dos.of up   Betamethasone sod.phosph.equiv.to betamethasone.
   nat., chicken pox, measl., known/susp. threadworm .infestat.,   to 250 mg IV over at least 5 mins., if dos.great.than 250 mg admin.   Indications: Subsit.ther.in treat.adren.insuff.in pts.with known/
   poss.impair.mineralocortic. secret., postpone poliovir.vacc.esp.  over at least 30 min. Thereaft.either IV/IM accord. to pt.respons.&   suspect.adren.insuff.prior to surg./ shock/sev.trauma/other stress
   those in close cont. with pt., concom.antidiab.agents, pt. super-  clinic.condit.  condits., sympt. treatm.of inflam.condits.respons.to corticoster. ther.
   vis. aft.ther.cessat., diet.salt restrict., K -supplem., monit.all pts.  Infts.& childr: Depend.on sev.of condit.& respons. but not less than   (S4) INJ. 32/21.5.1/0338. 4 mg/ml.
                    +
   for evid.of intercurr.infect.  0,5 mg/kg every 24 hrs.     8991240-006: 10x1 ml amps, R106,33
   Drug interactions: Poss.seiz.with concom. ciclosp., reduc.eff.with   Admin.separat.from other IV meds.  Dosage: . Admin.IV/IM/intra-artic./intrales.or by infus.in dos.equiv.
   meds.induc.hepat.enzym., incr. adverse effs.with meds.inhib.metab.  Contra-indications: Cert.act.virus., psychot. states not contr.by   to 4-20 mg. May also be giv.by loc.inj.into soft tiss.in dos.equiv.to
   eg. erythromycin/ketoconazole, incr.salicylat.excret., incr. infect.risk   treatm., live attenuat.vacc., syst.fung.infects., haemorrh.disords./   4-8 mg. Indiv. freq.& route of admin.accord.to dis./condit.sev./pt.
   with other immunosuppress., sev. hypokalaem. with diurets./car-  ongo. anticoag.treatm.in IM inj., ac.psychos./ pept.ulc./ osteoporos.,   respons.& toler. Admin.slow./by infus.as CV collapse report.with
   bon.anhydras. inhib./ amphotericin B, incr.card.dysrhythm.risk with   safety in pregn.& lactat.not est.  rapid IV inj.of massive dos.
   digoxin, incr.eff.with coumar.anticoags., sev. weakn.in myasth.grav.  Side-effects: Gen.allerg.reacts.& anaphylax., flush., seiz., reactivat.  Contraindications: Intrathec./subconjunct. admin., osteoporos.,
   pts.with anticholinest. agents, reduc.hypotens.with antihypertens.,   of latent infects., opportunist. infects., diab.mellit., Cushing’s syndr.   psychos.& sev.psychoneuros., pept.ulc., quiesc./act.TB, ac.vir.in-
   incr. corticoster. clear.with meds.induc.hepat.enzym., atten. live vacc.  effs., hypokalaem.syndr., prot.catabol.with negat. nitrog. bal., psych.  fects., pregn.& lactat., live vaccine admin.
   poss.potent.vacc.virus replicat., poss. incr./prolong.resp.depress./  disturbs., CNS effs., incr.IC press., pseudomot. cerebri, eye disords.  Side effects: Electrol.disturbs.charact.by hypertens. / oed., hypoka-
   paralys.with nondepolaris. neuromusc.block.agents, incr.bld. gluc.  incl. sudd.blindn., CHF, GI disords., incr.appet., weight gain, pancre-  laem.alkalos., incr. suscept. to infect./sepsis/TB/fung.& vir.infects.,
   conc.with oral antidiab.agents & insul.  atit., pept.ulcerat., intest.perforat., oesophagit., adren.suppress.,   delay. wound heal., ac.adren.insuff.dur.prolong. ther./ cessat./stress,
   MEDROL, Pfizer [N/P/S in C]  hirsutism, skin disords. incl.tissue atrophy, petechiae, ecchymos.,   growth retardat.in childr., Cushingoid sympt., osteoporos./spontan.
                                                              fract., nitrog. deplet., hyperglycaem., amenorrh., hyperhidros., skin
   Methylprednisolone.          thin fragile skin, hair & scalp thinn., hyper-/hypopigment., avascul.  thin., ocul.chang.incl.cataract, ment./ neurolog.disturbs., IC-hyper-
   Indications: Rheumat., ocul., allerg., dermatol. disords.& other   necros., musc.weakn., osteoporos., bone fract., steroid myopathy,
   condit.respons.to anti-inflammat. corticoster.  tendon rupt., loc.reacts., poss.life-threat.adren.insuffic. &/ withdr.  tens., ac. pancreatit., musc.weakn., asept.bone necros., incr. bld.
                                                              coagulabil.& thrombo-embolyt.compl.
   (S4) TABS. C729, C728.       syndr.not relat.to HPA axis suppress.with too rapid dos.reduct.foll.
   741116-006: 4 mg, 30, R55,27  prolong.treatm., poss. incr. bld. gluc.conc.  Special precautions: Poss.tox.eff.from withdr. /cont. use/large
                                                              dos., poss.foet./neonat.adren. depress. in high dos.dur.pregn., CHF,
   741116-014: 4 mg, 100, R184,32  Special precautions: Excret.in breast milk, angioed./ anaphylact.
   741124-009: 16 mg, 50, R304,89  reacts./seiz.& sudd.death assoc. with card. arrhythm.report with   hypertens., diab. mellit., epilep., glauc., infect.dis., ocul. H.simplex,
                                                              chron.ren.fail., uraem., elderly, quiesc. TB should rec.chemopro-
   Dosage: 4-48 mg dly. Indiv.accord.to condit.& respons. Maint./ad-  rapid admin. of high dos., also bradycard., ECG.monit. recomm.&   phylax.if ther.prolong., poss. incr.antidiab./antihypertens.requirm.
   just init.dos.until satisfact. respon.noted., discont.ther.& transf.pt to   treatm.facilit.avail. , poss. exacerbat./ reactivat.of TB., may mask   Drug interactions: Barbits./carbamazepine/ phenytoin /primidone/
   other appropr.ther.if lack.of satisfact.clin.respon.observ. aft. reason-  infects./new infects., incr.dos.poss.reqd.prior to/dur.& for some time   rifampicin may reduc.eff., K-deplet. diuret.may cause excess.K-loss,
   ab.period. With favour.respons.determ. maint.dos.by decr.init.dos.  NSAID’s incr. GI bleed.& ulcerat., poss.decr.salicyl.ser. conc., anti-
   in small increm.until. low. dos.to maint.adeq.clinic.respons.reach.  When adverse reactions or side   muscarin.eff.poss.decr.in myasth.grav., interfer. with assay proced.
   Alternate day ther (ADT) regimen: Twice the usual dly. dos.  of endogen.subst.
   of cortic.admin.every other morn.to provide pt. requir.long-term   effects, e.g. fatigue, sedation,
   pharmacolog.dose treatm. with benefic.eff.of cortic.while mini-  PHARMA-Q DEXAMETHASONE PHOSPHATE INJECTION
   mis. undesir. effs incl.pituit-adrenal suppress., cushingoid state,   impaired psychomotor function   4 mg/1 ml, Pharma-Q [N/P/S in C]
   cortic.withdraw.sympts.& growth suppress.in childr. Indiv.accord.  and visual disturbances have been   Dexamethasone phosph.
   to pt.condit.& respons                                     Indications: Where anti-inflamm.& immunosuppress. eff.of cor-
   Contraindications: System.fung.infects., immunizat. proced.  reported, patients should be advised   ticoster.desir.
   Side-effects: Fluid & electrol.disturbs., CCF, hypertens., musc.  not to engage in any activity which   (S4) INJ. 33/21.5.1/0512. 4 mg/ml.
   weakn., osteoporos., GI disturbs., imp.wound heal., thin skin, rash.,   701589-001: 10x1 ml amps, R91,06
   incr.IC-press., convuls., headache, vertigo, Cushingoid state, men-  requires alert motor and other skills,   Dosage: Admin.slow IV/IM.
   str. disturbs., incr.IOP, glauc., psychic. disturbs., vertebr.compress.   such as driving, operating machinery   Adults: Range: 0,5-20 mg dly accord.to severity.
   fracts., steroid myopathy, asept.necros.of femor./humeral heads.,   Cerebr.oed.caus.by malign: Init.IV dos: 10 mg usual.giv.foll.
   loss of musc.mass, pathologic.fract.of long bones, facial erythema,   or climbing dangerous heights until   by 4 mg IM 6 hrly.
   incr.sweat., petech.& ecchymos., may suppress react.to skin tests,   they know how the medication   Respons.usual.obtain.aft.12-24 hrs.& dos.may be reduc.aft.2-4 days.
   suppress.of growth & pituit.hormone in childr., decr.carbohydr. tol.  May be admin.by intra-artic./intrales./IM/soft tiss.inj.
   incl. manifestat.of lat.diab.mellit.& incr.insul. / oral hypoglycaem. affects them, or are instructed by their   Intra-articul.inj: Dos.equiv.to 0,8-4 mg giv. depend. on size of
   agents requirem., second. adrenocortic. & pituit.unresponsiven.  treating clinician not to do so.  the joint.
   partic.in stress, poster.subcapsul.cataracts, exophthalmos, neg. ni-  Contraindications: Act./quiesc.TB, psychos., sev. psychoneu-
   trog. bal.due to prot.catabol.                             ros., ac.infect., pept.ulc., osteoporos., safety in pregn.& lactat.not</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page336.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page332.html">332</a>&nbsp;&nbsp;&nbsp;<a href="page333.html">333</a>&nbsp;&nbsp;&nbsp;<a href="page334.html">334</a>&nbsp;&nbsp;&nbsp;<a href="page335.html">335</a>&nbsp;&nbsp;&nbsp;<a href="page336.html">336</a>&nbsp;&nbsp;&nbsp;<a href="page337.html">337</a>&nbsp;&nbsp;&nbsp;<a href="page338.html">338</a>&nbsp;&nbsp;&nbsp;<a href="page339.html">339</a>&nbsp;&nbsp;&nbsp;<a href="page340.html">340</a>&nbsp;&nbsp;&nbsp;<a href="page341.html">341</a>&nbsp;&nbsp;&nbsp;<a href="page342.html">342</a>
             </td>
             <td width="35%"><a href="page338.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page338.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
